Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,285.96
(
0.12%
)
News Focus
News Focus
Post# of 48316
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

ash111

Send PM Follow Ignore
Followers 1052
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

ash111

Re: None

Friday, 10/13/2017 2:53:50 PM

Friday, October 13, 2017 2:53:50 PM

Post# of 48316
$ONCS $MRK " Under the agreement, OncoSec will sponsor and fund the study and Merck will provide KEYTRUDA". KEYTRUDA® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.
ImmunoPulse® is a registered trademark of OncoSec Medical Incorporated, San Diego, CA, USA.

$ONCS Anticipated Study Start Date:
October 15, 2017
https://www.clinicaltrials.gov/ct2/show/NCT03132675?term=NCT03132675.&rank=1

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote